Trgovina Insmed - INSM CFD
Dodaj med priljubljene- Povzetek
- Zgodovinski podatki
- Dogodki
- Izkaz poslovnega izida
- Bilanca stanja
- Denarni tok
- Lastništvo
Razmik | - | ||||||||
Nočna pristojbina za nakup
Long position overnight fee
Pojdi na platformo | -0.025457% | ||||||||
Nočna pristojbina za prodajo
Short position overnight fee
Pojdi na platformo | 0.003235% | ||||||||
Čas nočne pristojbine | 21:00 (UTC) | ||||||||
Min. tržena količina | 1 | ||||||||
Valuta | USD | ||||||||
Kritje | 20% | ||||||||
Borza | United States of America | ||||||||
Provizija na trgovanje | 0% |
*Information provided by Capital.com
Insmed Inc ESG Risk Ratings
‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.
Predhodno. Zapri* | N/A |
Odpri* | N/A |
Enoletna sprememba* | N/A |
Dnevni razpon* | N/A |
Razpon 52 wk | 16.04-28.94 |
Povprečni obseg (10 dni) | 932.96K |
Povprečni obseg (3 meseci) | 23.64M |
Tržna kapitalizacija | 2.65B |
Razmerje P/E | -100.00K |
Število delnic v obtoku | 136.43M |
Prihodki | 257.47M |
EPS | -4.26 |
Dividenda (donosnost v %) | N/A |
Beta | 1.52 |
Datum naslednjega zaslužka | Aug 2, 2023 |
Vse podatke je zagotovil Refinitiv, razen podatkov, označenih z zvezdico, ki so *podatki, ki jih je zagotovil Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Zapiranje | Change | Change (%) | Odpiranje | High | Low |
---|
Insmed Events
Čas (UTC) (UTC) | Država | Dogodek |
---|---|---|
Wednesday, August 2, 2023 | ||
Čas (UTC) (UTC) 12:30 | Država US
| Dogodek Q2 2023 Insmed Inc Earnings Release Q2 2023 Insmed Inc Earnings ReleaseForecast -Previous - |
Wednesday, October 25, 2023 | ||
Čas (UTC) (UTC) 12:30 | Država US
| Dogodek Q3 2023 Insmed Inc Earnings Release Q3 2023 Insmed Inc Earnings ReleaseForecast -Previous - |
- Letni
- Četrtletno
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Skupni prihodki | 245.358 | 188.461 | 164.413 | 136.467 | 9.835 |
Prihodki | 245.358 | 188.461 | 164.413 | 136.467 | 9.835 |
Celotni odhodki iz poslovanja | 702.679 | 581.244 | 429.645 | 371.712 | 319.382 |
Celotna prodaja/splošni/upravni stroški Odhodki | 265.784 | 234.273 | 203.613 | 210.796 | 168.218 |
Raziskave in razvoj | 397.518 | 272.744 | 181.157 | 131.711 | 145.283 |
Prihodki iz poslovanja | -457.321 | -392.783 | -265.232 | -235.245 | -309.547 |
Prihodki (odhodki) od obresti, neto Neoperativni | -15.365 | -40.299 | -27.861 | -17.784 | -15.131 |
Drugo, neto | -7.465 | -3.33 | 0.405 | -0.531 | 0.602 |
Čisti dobiček pred obdavčitvijo | -480.151 | -436.412 | -292.688 | -253.56 | -324.076 |
Čisti dobiček po davkih | -481.534 | -434.654 | -294.09 | -254.337 | -324.277 |
Čisti dobiček pred dodatnimi postavkami | -481.534 | -434.654 | -294.09 | -254.337 | -324.277 |
Čisti dobiček | -481.534 | -434.654 | -294.09 | -254.337 | -324.277 |
Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk | -481.534 | -434.654 | -294.09 | -254.337 | -324.277 |
Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami | -481.534 | -434.654 | -294.09 | -254.337 | -324.277 |
Popravljen čisti dobiček | -481.534 | -434.654 | -294.09 | -254.337 | -324.277 |
Popravljene ponderirane povprečne delnice | 123.035 | 112.111 | 97.605 | 84.56 | 76.889 |
Popravljen dobiček na delnico brez upoštevanja izrednih postavk | -3.9138 | -3.877 | -3.01306 | -3.00777 | -4.21747 |
Dividends per Share - Common Stock Primary Issue | |||||
Popravljen normalizirani dobiček na enoto čistega dobička | -4.02369 | -3.73192 | -3.01306 | -3.00777 | -4.1988 |
Celotni stroški prihodkov | 55.126 | 44.152 | 39.872 | 24.212 | 2.423 |
Bruto dobiček | 190.232 | 144.309 | 124.541 | 112.255 | 7.412 |
Depreciation / Amortization | 5.053 | 5.052 | 5.003 | 4.993 | 1.249 |
Nenavadni odhodki (prihodki) | -20.802 | 25.023 | 0 | 0 | 2.209 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Skupni prihodki | 65.214 | 59.3 | 67.73 | 65.221 | 53.107 |
Prihodki | 65.214 | 59.3 | 67.73 | 65.221 | 53.107 |
Celotni stroški prihodkov | 13.83 | 13.069 | 13.471 | 16.395 | 12.191 |
Bruto dobiček | 51.384 | 46.231 | 54.259 | 48.826 | 40.916 |
Celotni odhodki iz poslovanja | 213.372 | 210.775 | 195.427 | 153.537 | 142.94 |
Celotna prodaja/splošni/upravni stroški Odhodki | 79.914 | 73.479 | 75.583 | 59.974 | 56.748 |
Raziskave in razvoj | 127.865 | 124.763 | 99.872 | 88.527 | 84.356 |
Depreciation / Amortization | 1.263 | 1.264 | 1.263 | 1.263 | 1.263 |
Prihodki iz poslovanja | -148.158 | -151.475 | -127.697 | -88.316 | -89.833 |
Prihodki (odhodki) od obresti, neto Neoperativni | -9.479 | -8.127 | -1.562 | -2.522 | -3.154 |
Drugo, neto | -1.644 | -0.396 | -1.514 | -4.306 | -1.249 |
Čisti dobiček pred obdavčitvijo | -159.281 | -159.998 | -130.773 | -95.144 | -94.236 |
Čisti dobiček po davkih | -159.764 | -160.123 | -131.145 | -95.645 | -94.621 |
Čisti dobiček pred dodatnimi postavkami | -159.764 | -160.123 | -131.145 | -95.645 | -94.621 |
Čisti dobiček | -159.764 | -160.123 | -131.145 | -95.645 | -94.621 |
Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk | -159.764 | -160.123 | -131.145 | -95.645 | -94.621 |
Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami | -159.764 | -160.123 | -131.145 | -95.645 | -94.621 |
Popravljen čisti dobiček | -159.764 | -160.123 | -131.145 | -95.645 | -94.621 |
Popravljene ponderirane povprečne delnice | 136.355 | 132.8 | 120.789 | 119.602 | 118.929 |
Popravljen dobiček na delnico brez upoštevanja izrednih postavk | -1.17168 | -1.20575 | -1.08574 | -0.79969 | -0.79561 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
Popravljen normalizirani dobiček na enoto čistega dobička | -1.21696 | -1.21456 | -1.05755 | -0.86829 | -0.85911 |
Nenavadni odhodki (prihodki) | -9.5 | -1.8 | 5.238 | -12.622 | -11.618 |
- Letni
- Četrtletno
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Kratkoročna sredstva skupaj | 1273.38 | 837.04 | 622.892 | 555.194 | 518.946 |
Denarna sredstva in kratkoročne naložbe | 1148.28 | 716.782 | 532.756 | 487.429 | 495.072 |
Denarna sredstva in ustrezniki | 1074.04 | 716.782 | 532.756 | 487.429 | 495.072 |
Prepaid Expenses | 25.468 | 28.898 | 23.982 | 20.22 | 11.327 |
Total Assets | 1656.44 | 1243.51 | 796.155 | 742.299 | 604.556 |
Property/Plant/Equipment, Total - Net | 102.082 | 95.516 | 97.233 | 113.109 | 22.636 |
Property/Plant/Equipment, Total - Gross | 141.527 | 132.577 | 125.583 | 132.376 | 36.809 |
Accumulated Depreciation, Total | -39.445 | -37.061 | -28.35 | -19.267 | -14.173 |
Intangibles, Net | 68.756 | 73.809 | 49.261 | 53.682 | 58.675 |
Other Long Term Assets, Total | 76.104 | 50.99 | 26.769 | 20.314 | 4.299 |
Total Current Liabilities | 190.243 | 135.166 | 118.807 | 85.24 | 79.732 |
Accounts Payable | 52.61 | 35.784 | 42.853 | 13.184 | 17.741 |
Accrued Expenses | 136.416 | 98.773 | 74.873 | 70.555 | 60.462 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 1.217 | 0.609 | 1.081 | 1.221 | |
Other Current Liabilities, Total | 0 | 0.28 | 1.529 | ||
Total Liabilities | 1568.48 | 833.04 | 520.271 | 480.625 | 396.29 |
Total Long Term Debt | 1154.89 | 580.691 | 371.031 | 355.469 | 316.558 |
Long Term Debt | 1125.25 | 566.588 | 356.318 | 335.94 | 316.558 |
Other Liabilities, Total | 223.355 | 117.183 | 30.433 | 39.916 | 0 |
Total Equity | 87.951 | 410.468 | 275.884 | 261.674 | 208.266 |
Common Stock | 1.357 | 1.187 | 1.028 | 0.897 | 0.773 |
Additional Paid-In Capital | 2782.42 | 2673.56 | 2105.25 | 1797.29 | 1489.66 |
Retained Earnings (Accumulated Deficit) | -2696.58 | -2265.24 | -1830.59 | -1536.5 | -1282.16 |
Other Equity, Total | 0.756 | 0.968 | 0.193 | -0.01 | -0.009 |
Total Liabilities & Shareholders’ Equity | 1656.44 | 1243.51 | 796.155 | 742.299 | 604.556 |
Total Common Shares Outstanding | 135.654 | 118.738 | 102.763 | 89.6824 | 77.3075 |
Celotne terjatve, neto | 29.713 | 24.351 | 16.562 | 19.232 | 5.515 |
Accounts Receivable - Trade, Net | 29.713 | 24.351 | 16.562 | 19.232 | 5.515 |
Total Inventory | 69.922 | 67.009 | 49.592 | 28.313 | 7.032 |
Capital Lease Obligations | 29.636 | 14.103 | 14.713 | 19.529 | |
Goodwill, Net | 136.11 | 136.11 | |||
Long Term Investments | 0 | 50.043 | |||
Kratkoročne naložbe | 74.244 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Kratkoročna sredstva skupaj | 1129.06 | 1273.38 | 632.165 | 674.726 | 756.14 |
Denarna sredstva in kratkoročne naložbe | 998.681 | 1148.28 | 513.295 | 554.868 | 635.119 |
Denarna sredstva in ustrezniki | 968.907 | 1074.04 | 414.633 | 416.078 | 515.704 |
Celotne terjatve, neto | 30.523 | 29.713 | 27.401 | 29.481 | 25.722 |
Accounts Receivable - Trade, Net | 30.523 | 29.713 | 27.401 | 29.481 | 25.722 |
Total Inventory | 71.317 | 69.922 | 66.276 | 67.017 | 64.145 |
Prepaid Expenses | 28.542 | 25.468 | 25.193 | 23.36 | 31.154 |
Total Assets | 1517.72 | 1656.44 | 994.817 | 1053.35 | 1153.31 |
Property/Plant/Equipment, Total - Net | 103.729 | 102.082 | 92.811 | 95.171 | 101.767 |
Property/Plant/Equipment, Total - Gross | 144.407 | 141.527 | 130.833 | 134.476 | 140.114 |
Accumulated Depreciation, Total | -40.678 | -39.445 | -38.022 | -39.305 | -38.347 |
Intangibles, Net | 67.493 | 68.756 | 70.02 | 71.283 | 72.546 |
Other Long Term Assets, Total | 81.322 | 76.104 | 63.711 | 66.3 | 57.201 |
Total Current Liabilities | 187.984 | 190.243 | 137.654 | 113.816 | 125.249 |
Accounts Payable | 59.278 | 52.61 | 11.576 | 31.144 | 48.571 |
Accrued Expenses | 126.548 | 136.416 | 125.741 | 82.46 | 76.553 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 2.158 | 1.217 | 0.337 | 0.212 | 0.125 |
Total Liabilities | 1562.37 | 1568.48 | 1024.78 | 1009.11 | 1033.44 |
Total Long Term Debt | 1161.2 | 1154.89 | 807.478 | 807.112 | 806.665 |
Long Term Debt | 1132.19 | 1125.25 | 784.799 | 783.977 | 783.156 |
Capital Lease Obligations | 29.015 | 29.636 | 22.679 | 23.135 | 23.509 |
Other Liabilities, Total | 213.183 | 223.355 | 79.644 | 88.185 | 101.521 |
Total Equity | -44.653 | 87.951 | -29.959 | 44.241 | 119.88 |
Common Stock | 1.364 | 1.357 | 1.217 | 1.199 | 1.193 |
Additional Paid-In Capital | 2809.24 | 2782.42 | 2506.67 | 2449.28 | 2428.58 |
Retained Earnings (Accumulated Deficit) | -2856.34 | -2696.58 | -2536.46 | -2405.31 | -2309.67 |
Other Equity, Total | 1.083 | 0.756 | -1.386 | -0.929 | -0.23 |
Total Liabilities & Shareholders’ Equity | 1517.72 | 1656.44 | 994.817 | 1053.35 | 1153.31 |
Total Common Shares Outstanding | 136.429 | 135.654 | 121.726 | 119.865 | 119.346 |
Goodwill, Net | 136.11 | 136.11 | 136.11 | 136.11 | 136.11 |
Long Term Investments | 0 | 0 | 9.764 | 29.551 | |
Kratkoročne naložbe | 29.774 | 74.244 | 98.662 | 138.79 | 119.415 |
- Letni
- Četrtletno
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Čisti prihodki/začetna postavka | -481.534 | -434.654 | -294.09 | -254.337 | -324.277 |
Denarna sredstva iz poslovanja | -400.439 | -363.302 | -219.348 | -250.649 | -257.977 |
Denarna sredstva iz poslovanja | 7.238 | 10.208 | 10.225 | 5.548 | 3.577 |
Nedenarne postavke | 62.229 | 114.672 | 62.468 | 56.116 | 45.738 |
Cash Taxes Paid | 1.717 | 1.558 | 0.814 | 0.339 | 0.154 |
Denarna sredstva Plačane obresti | 10.157 | 10.89 | 9.186 | 7.883 | 6.289 |
Spremembe v obratnem kapitalu | 6.575 | -58.58 | -2.954 | -62.969 | 15.736 |
Denarna sredstva pri naložbenju | -34.584 | -64.285 | -6.822 | -42.268 | -14.814 |
Kapitalski izdatki | -9.878 | -7.289 | -6.822 | -42.268 | -14.814 |
Celotne druge postavke denarnih tokov pri naložbenju | -24.706 | -56.996 | |||
Denarna sredstva pri financiranju | 793.273 | 612.546 | 271.003 | 285.278 | 386.743 |
Postavke denarnega toka pri financiranju | -18.384 | -16.799 | 0 | 4.503 | -14.237 |
Izdaja (odplačilo) delnic, neto | 311.657 | 291.923 | 271.939 | 280.775 | 8.815 |
Izdaja (odplačilo) dolga, neto | 500 | 337.422 | -0.936 | 0 | 392.165 |
Učinki deviznih tečajev | -0.996 | -0.933 | 0.494 | -0.004 | -0.045 |
Neto sprememba denarnih sredstev | 357.254 | 184.026 | 45.327 | -7.643 | 113.907 |
Amortization | 5.053 | 5.052 | 5.003 | 4.993 | 1.249 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -159.764 | -481.534 | -321.411 | -190.266 | -94.621 |
Cash From Operating Activities | -146.303 | -400.439 | -297.29 | -207.462 | -105.161 |
Cash From Operating Activities | 1.926 | 7.238 | 4.941 | 3.609 | 2.015 |
Amortization | 1.263 | 5.053 | 3.789 | 2.526 | 1.263 |
Non-Cash Items | 31.012 | 62.229 | 37.639 | 14.25 | 4.396 |
Cash Taxes Paid | 1.004 | 1.717 | 1.626 | 1.194 | 0.635 |
Cash Interest Paid | 11.589 | 10.157 | 7.442 | 5.004 | 2.375 |
Changes in Working Capital | -20.74 | 6.575 | -22.248 | -37.581 | -18.214 |
Cash From Investing Activities | 41.602 | -34.584 | -54.893 | -104.311 | -101.407 |
Capital Expenditures | -3.398 | -9.878 | -5.187 | -4.605 | -1.701 |
Cash From Financing Activities | -0.399 | 793.273 | 49.886 | 12.77 | 6.459 |
Issuance (Retirement) of Stock, Net | 1.139 | 311.657 | 50.716 | 13.264 | 6.818 |
Issuance (Retirement) of Debt, Net | -0.32 | 500 | -0.83 | -0.494 | -0.359 |
Foreign Exchange Effects | -0.029 | -0.996 | 0.148 | -1.701 | -0.969 |
Net Change in Cash | -105.129 | 357.254 | -302.149 | -300.704 | -201.078 |
Financing Cash Flow Items | -1.218 | -18.384 | 0 | 0 | |
Other Investing Cash Flow Items, Total | 45 | -24.706 | -49.706 | -99.706 | -99.706 |
Ime vlagatelja | Vrsta vlagatelja | Odstotek neporavnanih obveznosti | Delnice v lasti | Sprememba delnic | Datum imetništva | Ocena prometa |
---|---|---|---|---|---|---|
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 9.7735 | 13334302 | 322480 | 2023-03-31 | LOW |
T. Rowe Price Associates, Inc. | Investment Advisor | 7.146 | 9749543 | 270 | 2023-03-31 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 6.5852 | 8984332 | -498924 | 2023-03-31 | LOW |
T. Rowe Price Investment Management, Inc. | Investment Advisor | 6.1682 | 8415430 | 40755 | 2023-03-31 | MED |
Deep Track Capital LP | Hedge Fund | 4.7643 | 6500000 | 2235708 | 2023-03-31 | HIGH |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 4.6361 | 6325205 | -561482 | 2023-03-31 | LOW |
Palo Alto Investors LP | Hedge Fund | 4.3168 | 5889491 | 18200 | 2023-03-31 | LOW |
Macquarie Investment Management | Investment Advisor | 2.9702 | 4052364 | 401559 | 2023-03-31 | LOW |
Pictet Asset Management Ltd. | Investment Advisor/Hedge Fund | 2.8811 | 3930763 | -55786 | 2023-03-31 | LOW |
William Blair Investment Management, LLC | Investment Advisor/Hedge Fund | 2.7169 | 3706678 | 316513 | 2023-03-31 | LOW |
Franklin Advisers, Inc. | Investment Advisor/Hedge Fund | 2.5517 | 3481295 | 459 | 2023-03-31 | LOW |
Bellevue Asset Management AG | Investment Advisor | 2.4137 | 3293102 | 15895 | 2023-03-31 | LOW |
Fidelity Management & Research Company LLC | Investment Advisor | 2.3531 | 3210367 | -181407 | 2023-03-31 | LOW |
Suvretta Capital Management, LLC | Hedge Fund | 2.1491 | 2932138 | 411237 | 2023-03-31 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.9245 | 2625675 | 129286 | 2023-03-31 | LOW |
Janus Henderson Investors | Investment Advisor/Hedge Fund | 1.8772 | 2561169 | -435083 | 2023-03-31 | LOW |
AllianceBernstein L.P. | Investment Advisor/Hedge Fund | 1.8136 | 2474388 | -129796 | 2023-03-31 | LOW |
Holocene Advisors, LP | Hedge Fund | 1.6236 | 2215147 | 76280 | 2023-03-31 | HIGH |
Samlyn Capital, LLC | Hedge Fund | 1.4495 | 1977556 | 39261 | 2023-03-31 | HIGH |
Emerald Advisers LLC | Investment Advisor | 1.3387 | 1826406 | 84347 | 2023-03-31 | MED |
Zakaj izbrati Capital.com? Številke govorijo same zase.
Capital.com Group535K+
Borzni posredniki
87K+
Aktivne stranke mesečno
$113M+
Mesečni obseg naložb
$64M+
Dvigi vsak mesec
Kalkulator trgovanja
Izračunajte svoj hipotetični P&L, če bi trgovino s CFD odprli na določen datum (izberite datum) in jo zaprli na drug datum (izberite datum).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Insmed Company profile
O družbi Insmed
Insmed Incorporated je biofarmacevtsko podjetje, ki se ukvarja z zagotavljanjem izdelka ARIKAYCE (amikacin liposomska inhalacijska suspenzija), ki se uporablja za zdravljenje pljučne bolezni Mycobacterium avium complex kot del kombinacije antibakterijskih zdravil za odrasle bolnike z omejenimi možnostmi zdravljenja ali brez njih. V njegovi klinični fazi sta tudi brensokatib in treprostinil palmitil v prahu za inhaliranje (TPIP). Brensokatib je majhna molekula, peroralni, reverzibilni zaviralec dipeptidil peptidaze 1, ki se razvija za zdravljenje bolnikov z bronhiektazijami, cistično fibrozo (CF) in drugimi nevtrofilno posredovanimi boleznimi, vključno s kroničnim rinosinusitisom brez nosnih polipov (CRS) in hidradenitis suppurativa (HS). TPIP je inhalacijska oblika prozdelka treprostinila treprostinila palmitila, ki lahko nudi diferenciran profil izdelka za pljučno arterijsko hipertenzijo (PAH) in pljučno hipertenzijo, povezano z intersticijsko pljučno boleznijo (PH-ILD).
Industry: | Bio Therapeutic Drugs |
700 Us Highway 202/206
BRIDGEWATER
NEW JERSEY 08807
US
Izkaz poslovnega izida
- Annual
- Quarterly
Ljudje gledajo tudi
Še vedno iščete posrednika, ki mu lahko zaupate?
Pridružite se 535.000+ trgovcem po vsem svetu, ki so se odločili za trgovanje s Capital.com